24 results
POS AM
PBLA
Panbela Therapeutics, Inc.
29 Mar 24
Prospectus update (post-effective amendment)
5:08pm
and the development of our product candidates.
We rely on, and expect to continue to rely on, third parties for the supply of raw materials and manufacture of drug
424B4
et32jl dwvn
20 Jun 23
Prospectus supplement with pricing info
5:19pm
424B4
6ca3v tq9i8n5p5nvr
3 Oct 22
Prospectus supplement with pricing info
5:29pm
POS AM
n5nyf7gp f3itw48y
22 Jun 22
Prospectus update (post-effective amendment)
5:19pm